Monday, March 04, 2024 12:08:19 PM
MRNJ
OTCMarkets
SEC Filings
Form Type
1-A/A
Received
06/23/2023
“If you purchase Units in this offering, your ownership interest in our Common Stock will be diluted immediately, to the extent of the difference between the price to the public charged for each share in this offering and the net tangible book value per share of our Common Stock after this offering.”
“Dilution means a reduction in value, control or earnings of the shares the investor owns”
"Initially, we do not plan to use underwriters or pay any commissions. We will be selling our Units using our best efforts and no one has agreed to buy any of our Units. This Offering Circular permits our CEO to sell Units directly to the public, with no commission or other remuneration payable to him for any Units he may sell. Currently, there is no plan or arrangement to enter into any contracts or agreements to sell the Units through a broker or dealer, although this may change in the future. Our CEO will sell Units, and intends to offer them to friends, family members and business acquaintances."
https://www.otcmarkets.com/stock/MRNJ/disclosure
Recent MRNJ News
- Metatron Apps Unveils "Dr. AI" Health Assistant for Personalized Health Support • InvestorsHub NewsWire • 01/23/2024 01:23:40 PM
- Metatron Pioneers AI-driven Content Discovery and Issues Reverse Split Moratorium • InvestorsHub NewsWire • 12/12/2023 04:59:50 PM
- Alternative to AI-Powered Apps As ChatGPT Pauses Signups • AllPennyStocks.com • 11/20/2023 03:00:00 PM
- Alternative to AI-Powered Apps As ChatGPT Pauses Signups • AllPennyStocks.com • 11/20/2023 03:00:00 PM
- Firm Pioneers AI-Powered App with Real-Time Stock Insights • AllPennyStocks.com • 10/30/2023 06:30:00 PM
- Company Looks to Revolutionze Legal Communication with AI • AllPennyStocks.com • 09/25/2023 04:50:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM